Shufersal Ltd
Shufersal maintains a capital structure with a debt-to-equity ratio of 1.44, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.85, suggesting potential short-term liquidity constraints. Additionally, the firm's cash and equivalents amount to 1.34 billion ILS, which is insufficient to cover its long-term debt of 5.9 billion ILS, resulting in a net cash deficit. In terms of profitability, Shufersal's return on equity (ROE) stands at 17.32%, significantly outperforming the industry median for food retailers. Its return on assets (ROA) of 4.86% also reflects a strong asset utilization efficiency, although it is slightly below the top quartile of the industry. The company's operating income of 1.1 billion ILS and net income of 711 million ILS demonstrate robust earnings power relative to its revenue base of 14.49 billion ILS. Geographically, Shufersal's operations are concentrated in Israel, with no material international revenue disclosed. The company's segmental breakdown is not publicly detailed, but its primary revenue streams are derived from retail grocery and drug sales. This concentration exposes the company to local economic and regulatory risks. Looking ahead, Shufersal is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The company's capital expenditure of -271 million ILS indicates a reduction in investment, which may signal a focus on cost optimization rather than expansion. Analysts have assigned a mean price target of 53.05 ILS, with a median of 53.05 ILS, reflecting a consensus of moderate optimism. The company's risk profile is marked by a medium liquidity risk and a low dilution risk. The key liquidity flag is the negative net cash position after accounting for total debt, which could necessitate additional financing in the near term. However, the low dilution risk suggests that the company is unlikely to issue new shares in the near future, preserving shareholder value. Recent events, including the latest financial filings and analyst reports, indicate a stable operational environment for Shufersal. The company has not disclosed any material legal or regulatory issues, and its financial performance remains consistent with historical trends.
Business. Shufersal Ltd operates as a leading food and drug retailer in Israel, generating revenue primarily through the sale of groceries, household goods, and pharmaceutical products.
Classification. Shufersal is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a high confidence level of 0.92.
- Shufersal's ROE of 17.32% and ROA of 4.86% indicate strong profitability and asset efficiency.
- The company's debt-to-equity ratio of 1.44 suggests a moderate debt load, but its current ratio of 0.85 highlights liquidity concerns.
- Shufersal's operations are concentrated in Israel, exposing it to local economic and regulatory risks.
- Analysts project a stable revenue trajectory with a mean price target of 53.05 ILS.
- The company's low dilution risk and stable capital expenditure suggest a conservative financial strategy.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.